Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Lucira

An at-home COVID-19 and flu test gets FDA emergency use authorization

The Food and Drug Administration has approved an at-home test that can detect and discern between COVID-19 infection and two strains of the flu, Influenza A and B, continuing the shift from clinical to home-diagnostic care that blossomed during the height of the pandemic.

Tribune News Service · Mar 2, 2023

Lantern Bolsters Board With Columbia Care VP, Verano Taps M&A Pro, And Other Key Exec Moves

Top CEOs, investors and leaders in the cannabis industry will soon convene at the Benzinga Cannabis Capital Conference on Sept. 13-14 in Chicago.

Benzinga · Aug 31, 2022

Recap Of Thursday's Biotech Catalysts - End Of the Day Summary

The U.S. Food and Drug Administration (FDA) has accepted the Menarini Group and Radius Health’s (NASDAQ:RDUS), New Drug Application (NDA) for elacestrant for patients with ER+/HER2- advanced or metastatic breast cancer. The agency has granted Priority Review designation and assigned a target action date of February 17, 2023. Radius Health…

Benzinga · Aug 11, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

Lucira Health Shares Fall After Announcing Debt Facility Of $80M

Lucira Health Inc (NASDAQ: LHDX) has entered into a

Benzinga · Feb 8, 2022

Coverage From

Organisations

Food and Drug Administration

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Read news from The Economist, FT, and more,
with one subscription

Places

Chicago

15,620 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.